Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:APEN Apollo Endosurgery (APEN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Apollo Endosurgery Stock (NASDAQ:APEN) 30 days 90 days 365 days Advanced Chart Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Get Apollo Endosurgery alerts:Sign Up Key Stats Today's Range N/A50-Day Range$9.87▼$10.0052-Week Range N/AVolume1.66 million shsAverage Volume1.43 million shsMarket Capitalization$579.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewApollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas, inadvertent perforation of the GI tract, tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon, the treatment of swallowing disorders, esophageal stent fixation, and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX.Read More… Receive APEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Apollo Endosurgery and its competitors with MarketBeat's FREE daily newsletter. Email Address APEN Stock News HeadlinesWeight Loss Services Market Analysis Report 2024-2030, Featuring Profiles of Atkins Nutritionals, Precor, Apollo Endosurgery, Johnson Health Tech, Life Fitness, iFIT, Torque Fitness and MoreOctober 15, 2024 | globenewswire.comApollo Pipes Ltd 531761February 1, 2024 | morningstar.comURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.December 22, 2024 | Crypto Swap Profits (Ad)Astronaut Frank Borman, commander of the first Apollo mission to the moon, dead at 95November 12, 2023 | nypost.comApollo astronaut Ken Mattingly, who helped save the crew of Apollo 13, has diedNovember 5, 2023 | cnn.comGastric Band and Gastric Balloon Market to Witness Growth Acceleration | Apollo Endosurgery, Cousin Surgery, Spatz FGIA IncMay 10, 2023 | marketwatch.comApollo Endosurgery Full Year 2022 Earnings: Revenues Beat Expectations, EPS LagsApril 1, 2023 | finance.yahoo.comAPEN Apollo Endosurgery, Inc.March 29, 2023 | seekingalpha.comSee More Headlines APEN Stock Analysis - Frequently Asked Questions How were Apollo Endosurgery's earnings last quarter? Apollo Endosurgery, Inc. (NASDAQ:APEN) issued its quarterly earnings results on Sunday, October, 31st. The biotechnology company reported ($0.23) earnings per share for the quarter, topping analysts' consensus estimates of ($0.28) by $0.05. The biotechnology company had revenue of $16.35 million for the quarter, compared to analysts' expectations of $16.20 million. Apollo Endosurgery had a negative trailing twelve-month return on equity of 89.48% and a negative net margin of 51.84%. What other stocks do shareholders of Apollo Endosurgery own? Based on aggregate information from My MarketBeat watchlists, some other companies that Apollo Endosurgery investors own include Pfizer (PFE), Novavax (NVAX), NVIDIA (NVDA), Ocugen (OCGN), Canopy Growth (CGC), Inovio Pharmaceuticals (INO) and Meta Platforms (META). Company Calendar Last Earnings10/31/2021Today12/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:APEN CUSIPN/A CIK1251769 Webwww.apolloendo.com Phone(512) 279-5100Fax858-678-0900Employees202Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-39,840,000.00 Net Margins-51.84% Pretax Margin-51.08% Return on Equity-89.48% Return on Assets-33.76% Debt Debt-to-Equity Ratio1.04 Current Ratio2.35 Quick Ratio1.89 Sales & Book Value Annual Sales$76.86 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.69 per share Price / BookN/AMiscellaneous Outstanding Shares57,972,000Free Float47,943,000Market Cap$579.72 million OptionableNot Optionable Beta2.31 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report This page (NASDAQ:APEN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollo Endosurgery, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apollo Endosurgery With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.